Enveric Biosciences, Inc. (ENVB)
$1.41-1.40%Close
SELLCRISIS · day 5
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $841,787
- Avg volume
- 203.5K
- Beta
- 1.11
- P/E (TTM)
- -0.09
- Short % float
- 3.50%
- Days to cover
- 1.0
- SI change
- +3.2%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- ORGOSELLOrganogenesis Holdings Inc.CRISISQ 5$1.67-7.22%
- STROSELLSutro Biopharma, Inc.CRISISQ -6$20.49-2.61%
- VNDABUYVanda Pharmaceuticals Inc.RECOVERYQ 13$5.33+0.95%
- APUSSELLApimeds Pharmaceuticals US, IncCRISISQ -26$4.75-1.86%
- GLSIBUYGreenwich LifeSciences, Inc.RECOVERYQ 27$17.58+5.46%
- ARDXSELLArdelyx, Inc.CRISISQ 1$3.74-3.86%
- MDGLSELLMadrigal Pharmaceuticals, Inc.RECOVERYQ 16$511.97-0.92%
- PHIOBUYPhio Pharmaceuticals Corp.RECOVERYQ 3$1.17-0.85%
- FBLGBUYFibroBiologics, Inc. Common StockRECOVERYQ -32$1.35-6.25%
- BLTEBUYBelite Bio, IncRECOVERYQ 54$158.87-1.36%
- CELCSELLCelcuity Inc.RECOVERYQ 29$90.79-2.93%
- DMRABUYGalecto, Inc.RECOVERYQ -3$30.31-1.65%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
